Literature DB >> 32444781

The lasting impact of methocinnamox on opioid self-administration.

E Andrew Townsend1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32444781      PMCID： PMC7547696          DOI： 10.1038/s41386-020-0717-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  4 in total

Review 1.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

Review 2.  Extended-release injectable naltrexone for opioid use disorder: a systematic review.

Authors:  Brantley P Jarvis; August F Holtyn; Shrinidhi Subramaniam; D Andrew Tompkins; Emmanuel A Oga; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2018-03-24       Impact factor: 6.526

3.  Methadone and buprenorphine added to the WHO list of essential medicines.

Authors:  Greg Herget
Journal:  HIV AIDS Policy Law Rev       Date:  2005-12

4.  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

Authors:  Nana Wilson; Mbabazi Kariisa; Puja Seth; Herschel Smith; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586
  4 in total
  1 in total

Review 1.  The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review.

Authors:  Colleen G Jordan; Amy L Kennalley; Alivia L Roberts; Kaitlyn M Nemes; Tenzing Dolma; Brian J Piper
Journal:  Pharmacy (Basel)       Date:  2022-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.